Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Dogs with generalized discoid lupus erythematosus have similar symptoms to humans and need continuous treatment.

Lupus can cause hair loss and nail changes, with treatments available for both.

Two patients with lupus had an unusual type of hair loss not typical for the disease but improved with treatment.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

A patient with a rare form of lupus improved after treatment for skin ulcers and hair loss on the face and scalp.

The case shows how hard it is to tell apart Multiple Autoimmune Syndrome from other similar autoimmune conditions, but correct diagnosis is key for treatment to work.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Different hair care practices and conditions affect African American hair and scalp health, requiring specialized knowledge for treatment.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Damaged hair follicle stem cells can cause permanent hair loss, but understanding their role could lead to new treatments.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Genomic approach finds new possible treatments for hair loss.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Iron deficiency might contribute to hair loss in women.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.